40T — ISEC Healthcare Income Statement
0.000.00%
- SG$201.32m
- SG$198.01m
- SG$74.20m
- 85
- 44
- 52
- 68
Annual income statement for ISEC Healthcare, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 36.3 | 40.5 | 63 | 70 | 74.2 |
Cost of Revenue | |||||
Gross Profit | 16.1 | 17.9 | 28.8 | 31 | 32.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 29.4 | 31 | 45.6 | 52 | 56.4 |
Operating Profit | 6.95 | 9.5 | 17.3 | 18 | 17.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6.51 | 9.09 | 16.8 | 17.3 | 17.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.45 | 6.88 | 12.7 | 13.2 | 12.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 4.69 | 6.91 | 12.5 | 13 | 12.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 4.69 | 6.91 | 12.5 | 13 | 12.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.01 | 0.012 | 0.022 | 0.023 | 0.024 |
Dividends per Share |